By simple deduction, it turns out that for cancer types with impaired TGF-β signaling (cancer types where Equation 1 is not obeyed), obesity is expected to be associated with a reduced risk of cancer (see Figure 1). The gene discussed is TGFB1; the disease is obesity due to melanocortin 4 receptor deficiency.